Press Releases
Press Releases
-
September 9, 2019
Gilead Sciences and the Elton John AIDS Foundation Launch RADIAN Initiative to Address HIV in Eastern Europe and Central Asia (EECA) -
August 26, 2019
Gilead Sciences to Present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10 -
August 23, 2019
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration -
August 15, 2019
European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis -
August 9, 2019
China National Medical Products Administration Approves Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection -
August 7, 2019
Gilead Sciences Statement on U.S. Food and Drug Administration Advisory Committee’s Recommendation on Descovy for PrEP™ -
July 30, 2019
Gilead Sciences Announces Third Quarter 2019 Dividend -
July 30, 2019
Gilead Sciences Announces Second Quarter 2019 Financial Results -
July 23, 2019
Gilead Announces Latest Data in Ongoing HIV Cure Research Program -
July 23, 2019
Gilead Presents New Findings on Profile of Descovy® for Potential Use as HIV Pre-exposure Prophylaxis Compared With Truvada®